Ian R Carroll, MD
Anesthesiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 4
Offices
4 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Carroll’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A69807 · Current
Licensed to practise in California · since 1999 · expires 2027-01-31 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$73,393
Medicare paid this office $73,393 for 473 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 280 | $38,196 | $70 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 295 | $14,033 | $43 |
| Long return visit (40+ min) | 29 | $6,622 | $170 |
| Injection of blood or blood clot into spinal canal | 27 | $6,597 | $76 |
| New patient visit (60+ min) | 12 | $2,508 | $209 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 280 | $38,196 | $70 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 295 | $14,033 | $43 |
| Long return visit (40+ min) | 29 | $6,622 | $170 |
| Injection of blood or blood clot into spinal canal | 27 | $6,597 | $76 |
| New patient visit (60+ min) | 12 | $2,508 | $209 |
| Fluoroscopic guidance for spine or back muscle injection | 26 | $1,139 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $490 | $10 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $387 | $30 |
Who their Medicare patients are
473 Original Medicare patients in 2024. Average age 70 · Under 65 21% · 85 and older 7% · Women 63% · Also on Medicaid 27% · Health risk score 1.94. Above the middle of the specialty; the typical anesthesiology clinician is at 1.54.
Conditions among them: High blood pressure 75% · Depression 39% · Diabetes 35% · Chronic kidney disease 35% · Coronary heart disease 32% · Atrial fibrillation 27% · Cancer 24% · Heart failure 19% · COPD 17% · Dementia 12% · Stroke 10%.
The office billed $387,436, Medicare allowed $93,779 and paid $73,393; for 1,150 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 473 | 1,150 | 70 | 1.94 | $387,436 | $73,393 |
| 2023 | 172 | 557 | 67 | 1.30 | $258,980 | $37,653 |
| 2022 | 55 | 312 | 58 | 1.12 | $184,428 | $24,203 |
| 2021 | 242 | 635 | 66 | 1.84 | $225,202 | $44,331 |
| 2020 | 346 | 840 | 67 | 1.99 | $248,039 | $56,252 |
| 2019 | 268 | 562 | 69 | 1.83 | $185,866 | $39,676 |
| 2018 | 300 | 651 | 68 | 2.01 | $203,823 | $46,200 |
| 2017 | 379 | 848 | 69 | 1.68 | $304,742 | $58,942 |
| 2016 | 371 | 953 | 68 | 1.72 | $317,261 | $67,001 |
| 2015 | 244 | 456 | 67 | 1.46 | $191,035 | $40,587 |
| 2014 | 127 | 250 | 67 | 1.36 | $124,146 | $21,321 |
| 2013 | 165 | 304 | 66 | 1.40 | $131,439 | $24,920 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $10,433 | $73 |
| Long return visit (40+ min) | 39 | $9,105 | $121 |
| Injection of blood or blood clot into spinal canal | 30 | $6,879 | $77 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 81 | $3,793 | $45 |
| New patient visit (60+ min) | 15 | $2,447 | $163 |
| Fluoroscopic guidance for spine or back muscle injection | 30 | $1,325 | $25 |
| Return visit (30+ min) | 13 | $1,170 | $84 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $377 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 28 | $211 | $5 |
2022: 7 services
| Long return visit (40+ min) | 42 | $11,325 | $140 |
| Injection of blood or blood clot into spinal canal | 22 | $5,846 | $84 |
| New patient visit (60+ min) | 14 | $2,479 | $177 |
| Return visit (30+ min) | 13 | $1,201 | $86 |
| Fluoroscopic guidance for spine or back muscle injection | 22 | $1,185 | $26 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | $675 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 21 | $202 | $5 |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 181 | $25,587 | $65 |
| Long return visit (40+ min) | 27 | $5,172 | $152 |
| Injection of blood or blood clot into spinal canal | 21 | $3,940 | $79 |
| New patient visit (60+ min) | 11 | $2,063 | $188 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,754 | $117 |
| Return visit (30+ min) | 12 | $1,255 | $97 |
| Fluoroscopic guidance for spine or back muscle injection | 21 | $829 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $245 | $11 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 299 | $38,598 | $67 |
| Injection of blood or blood clot into spinal canal | 19 | $3,653 | $76 |
| Long return visit (40+ min) | 20 | $3,084 | $106 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,453 | $94 |
| Fluoroscopic guidance for spine or back muscle injection | 18 | $763 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $268 | $10 |
2019: 6 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 152 | $14,046 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $11,424 | $66 |
| Injection of blood or blood clot into spinal canal | 17 | $5,212 | $83 |
| Long return visit (40+ min) | 20 | $2,322 | $86 |
| Fluoroscopic guidance for spine or back muscle injection | 16 | $972 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $373 | $11 |
2018: 6 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 194 | $17,313 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 142 | $13,702 | $64 |
| Injection of blood or blood clot into spinal canal | 21 | $5,093 | $76 |
| Long return visit (40+ min) | 23 | $3,437 | $86 |
| Fluoroscopic guidance for spine or back muscle injection | 21 | $954 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $395 | $11 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 233 | $24,081 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 164 | $15,818 | $89 |
| Injection of blood or blood clot into spinal canal | 16 | $5,637 | $78 |
| Long return visit (40+ min) | 35 | $4,036 | $84 |
| New patient visit (60+ min) | 14 | $1,782 | $127 |
| Fluoroscopic guidance for spine or back muscle injection | 18 | $1,183 | $27 |
| Return visit (30+ min) | 11 | $773 | $70 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $488 | $11 |
2016: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 186 | $23,727 | $64 |
| Long return visit (40+ min) | 67 | $8,971 | $91 |
| Injection of blood or blood clot into spinal canal | 23 | $7,610 | $76 |
| New patient visit (60+ min) | 45 | $6,193 | $138 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 51 | $5,964 | $89 |
| Return visit (30+ min) | 43 | $3,995 | $69 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 29 | $2,286 | $38 |
| Fluoroscopic guidance for spine or back muscle injection | 20 | $1,259 | $27 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,046 | $35 |
2015: 6 services
| Long return visit (40+ min) | 84 | $13,417 | $93 |
| New patient visit (60+ min) | 74 | $11,107 | $150 |
| Return visit (30+ min) | 66 | $5,540 | $69 |
| New patient visit (45+ min) | 20 | $2,313 | $116 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 15 | $806 | $38 |
| Ultrasonic guidance for needle placement | 11 | $357 | $30 |
2014: 4 services
| Long return visit (40+ min) | 51 | $7,901 | $99 |
| New patient visit (60+ min) | 38 | $5,588 | $147 |
| Return visit (30+ min) | 23 | $1,610 | $70 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 24 | $1,006 | $37 |
2013: 7 services
| New patient visit (60+ min) | 34 | $4,957 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,177 | $91 |
| Long return visit (40+ min) | 29 | $2,890 | $93 |
| Return visit (30+ min) | 30 | $2,158 | $67 |
| Daily hospital management of continuous spinal drug administration | 12 | $1,959 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,491 | $62 |
| Short return visit (20+ min) | 12 | $531 | $44 |
Medicaid work
$15,072 in 2024
Medicaid paid $15,072 for 484 billed services this clinician did in 2024, up to 44 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 377 | $11,810 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 72 | $3,107 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 35 | $154 |
| 2024 | 484 | 3 | 44 | $15,072 |
| 2023 | 103 | 1 | 22 | $3,778 |
| 2021 | 172 | 2 | 31 | $4,204 |
| 2020 | 196 | 1 | 21 | $3,980 |
| 2018 | 38 | 1 | 13 | $1,294 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 103 | $3,778 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 158 | $3,696 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 14 | $508 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 196 | $3,980 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 38 | $1,294 |
Drugs they prescribed that Part D paid
$1,416
Pharmacies billed $1,416 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 25% of their Part D prescriptions (25 of 100) in 2024. Above the middle of the specialty; the typical anesthesiology clinician is at 0%.
97 generic and fewer than 11 brand-name prescriptions · $1,416 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Potassium Citrate Er | 17 | $353 | $21 |
| Oxycodone-Acetaminophen | 22 | $149 | $7 |
| Ondansetron | 27 | $141 | $5 |
Year by year
| 2024 | 100 | 27 | 25% (25) | None | $1,416 |
| 2023 | 110 | 28 | 21% (23) | None | $2,147 |
| 2022 | 112 | 31 | 25% (28) | None | $2,547 |
| 2021 | 114 | 29 | 26% (30) | None | $2,471 |
| 2020 | 105 | 30 | 26% (27) | None | $2,558 |
| 2019 | 147 | 22 | 20% (29) | 10% | $5,614 |
| 2018 | 157 | 38 | 17% (26) | None | $4,788 |
| 2017 | 333 | 63 | 12% (40) | 10% | $26,648 |
| 2016 | 740 | 127 | 9% (67) | 16% | $82,019 |
| 2015 | 741 | 146 | 8% (59) | 17% | $107,788 |
| 2014 | 352 | 73 | 10% (34) | 20% | $70,579 |
| 2013 | 372 | 81 | 13% (47) | 33% | $67,024 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Promethazine | 12 | $341 | $28 |
| Ondansetron | 30 | $177 | $6 |
| Topiramate | 12 | $158 | $13 |
| Oxycodone-Acetaminophen | 19 | $145 | $8 |
2022: 2 drugs
| Oxycodone-Acetaminophen | 27 | $245 | $9 |
| Ondansetron | 28 | $165 | $6 |
2021: 3 drugs
| Ondansetron Odt | 36 | $463 | $13 |
| Oxycodone-Acetaminophen | 26 | $256 | $10 |
| Topiramate | 13 | $211 | $16 |
2020: 3 drugs
| Ondansetron Odt | 31 | $485 | $16 |
| Oxycodone-Acetaminophen | 25 | $322 | $13 |
| Gabapentin | 11 | $211 | $19 |
2019: 3 drugs
| Gabapentin | 14 | $502 | $36 |
| Ondansetron Odt | 39 | $252 | $6 |
| Oxycodone-Acetaminophen | 28 | $212 | $8 |
2018: 5 drugs
| Gabapentin | 13 | $642 | $49 |
| Oxycodone-Acetaminophen | 24 | $326 | $14 |
| Ondansetron | 22 | $188 | $9 |
| Ondansetron Odt | 31 | $144 | $5 |
| Hydrochlorothiazide | 13 | $66 | $5 |
2017: 7 drugs
| Desipramine | 23 | $5,125 | $223 |
| Gabapentin | 56 | $2,218 | $40 |
| Duloxetine | 29 | $1,180 | $41 |
| Baclofen | 25 | $914 | $37 |
| Topiramate | 20 | $745 | $37 |
| Oxycodone-Acetaminophen | 24 | $354 | $15 |
| Ondansetron | 23 | $168 | $7 |
2016: 18 drugs
| Lyrica | 55 | $27,646 | $503 |
| Desipramine | 51 | $9,189 | $180 |
| Butrans | 18 | $5,589 | $311 |
| Gabapentin | 135 | $5,421 | $40 |
| Duloxetine | 70 | $5,250 | $75 |
| Acetazolamide | 21 | $4,333 | $206 |
| Tiagabine | 12 | $2,684 | $224 |
| Oxcarbazepine | 28 | $1,917 | $68 |
| Topiramate | 43 | $1,361 | $32 |
| Levetiracetam | 11 | $989 | $90 |
| Clonidine | 15 | $923 | $62 |
| Oxycodone-Acetaminophen | 22 | $858 | $39 |
| Baclofen | 19 | $750 | $39 |
| Mirtazapine | 29 | $515 | $18 |
| Bupropion Xl | 16 | $423 | $26 |
| Nortriptyline | 15 | $301 | $20 |
| Fludrocortisone Acetate | 12 | $268 | $22 |
| Ondansetron | 11 | $180 | $16 |
2015: 15 drugs
| Lyrica | 62 | $37,509 | $605 |
| Duloxetine | 123 | $16,484 | $134 |
| Suboxone | 21 | $9,409 | $448 |
| Buprenorphine-Naloxone | 17 | $9,098 | $535 |
| Desipramine | 56 | $8,709 | $156 |
| Gabapentin | 128 | $4,632 | $36 |
| Topiramate | 36 | $1,107 | $31 |
| Hydrocodone-Acetaminophen | 16 | $1,008 | $63 |
| Clonidine | 12 | $812 | $68 |
| Bupropion Xl | 18 | $624 | $35 |
| Nortriptyline | 32 | $593 | $19 |
| Oxycodone | 11 | $355 | $32 |
| Methadone | 13 | $300 | $23 |
| Mirtazapine | 20 | $290 | $14 |
| Baclofen | 12 | $208 | $17 |
2014: 9 drugs
| Lyrica | 39 | $21,962 | $563 |
| Duloxetine | 46 | $15,180 | $330 |
| Buprenorphine-Naloxone | 12 | $8,989 | $749 |
| Desipramine | 30 | $5,501 | $183 |
| Alendronate | 18 | $2,946 | $164 |
| Gabapentin | 43 | $2,409 | $56 |
| Topiramate | 12 | $906 | $75 |
| Baclofen | 14 | $101 | $7 |
| Zolpidem | 11 | $74 | $7 |
2013: 7 drugs
| Cymbalta | 62 | $25,478 | $411 |
| Lyrica | 27 | $7,774 | $288 |
| Desipramine | 37 | $4,722 | $128 |
| Gabapentin | 63 | $3,490 | $55 |
| Topiramate | 19 | $1,424 | $75 |
| Hydrocodone-Acetaminophen | 21 | $367 | $17 |
| Zolpidem | 12 | $64 | $5 |
Money from drug and device companies
$108 in 2025
| 2025 | 1 | 1 | None | $108 |
| 2023 | 1 | 1 | None | $171 |
| 2021 | 1 | 1 | None | $125 |
| 2020 | 1 | 1 | None | $93 |
| 2019 | 1 | 1 | None | $67 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Zavzpret | $108 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-06-12 | Zavzpret | $108 |
See earlier years (2023, 2021, 2020, 2019)
2023: $171
| Siemens Medical Solutions USA | Artis Icono Biplane | $171 | 1 payment
|
2021: $125
| Biohaven Pharmaceuticals | Nurtec Odt | $125 | 1 payment
|
2020: $93
| Siemens Medical Solutions USA | Artis Q | $93 | 1 payment
|
2019: $67
| Siemens Medical Solutions USA | Artis Q | $67 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922148931
- Licence
- CA A69807California A69807: Current · expires 2027-01-31
- Trained
- Columbia University College of Physicians and Surgeons, 1998
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A698070
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 1804 Embarcadero Rd, Ste 100, Palo Alto, CA, 94303
- NPI first listed
- 2007-02-07
- NPI last updated
- 2024-04-08
- NPI record certified
- 2024-04-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305